Schedule 13G ownership disclosure

ADC THERAPEUTICS SA

Common Shares, par value CHF 0.08 per share · CUSIP: H0036K147

Event date: 2025-06-16

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Point72 Asset Management, L.P.

    Shares: 7,831,425.00 · Class: 7.0%

  • Point72 Capital Advisors, Inc.

    Shares: 7,831,425.00 · Class: 7.0%

  • Steven A. Cohen

    Shares: 7,831,425.00 · Class: 7.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-002745
Form type
SCHEDULE 13G
Filer
ADC Therapeutics SA
CIK
CIK 1771910
Filed
Jun 17, 2025
Reporting period
Jun 16, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub